Pharmaceuticals Limited

Rediff.com » News » Pharmaceuticals Limited

News for Pharmaceuticals Limited

News
Business
Sports

How year's most extravagant wedding was made secure

Entry based on a QR code messaged on personal mobile phones, colour-coded paper wristbands for access to different zones, and a medical response preparedness reserved for heads of state helped......

Over 30% Covaxin takers reported adverse events: Study

Nearly one-third of 926 individuals who received Bharat Biotech's anti-Covid vaccine Covaxin reported 'adverse events of special interest,' or AESI, according to a one-year follow up study......

AstraZeneca's COVID-19 Vaccine: The TTS Factor

'It is admitted that the AZ vaccine can, in very rare cases, cause TTS.' IMAGE: A vial labelled 'AstraZeneca COVID-19 Vaccine'. Photograph: Illustration/Dado Ruvic/Reuters The controversial......

Licences of 14 Patanjali, Divya Pharma products suspended: U'khand to SC

The Uttarakhand State Licensing Authority on Tuesday told the Supreme Court that manufacturing licenses of 14 products of Patanjali Ayurved Ltd and Divya Pharmacy have been "suspended with......

Which Companies Has Amit Shah Invested In?

Amit A Shah holds a stake in 180 listed entities, according to data disclosed in his election affidavit. IMAGE: Bharatiya Janata Party leader Amit A Shah at a roadshow in Assam, April 21, 2024.......

'Bharat Serums and Vaccines portfolio can touch Rs 5K cr in 3-4 years'

'Mankind's experience, sharpness, and execution will make it happen. We are not going for short-term gains.' Kindly note the image has been posted only for representational purposes. Photograph:......

Mankind Pharma to lead in Indian women's health market after BSV deal

New Delhi-based pharmaceutical major Mankind Pharma is poised to take pole position in women’s health portfolio in the India Pharma Market (IPM) after completing the Rs 13,630 crore deal to......

Sebi's proposed tweaks likely to lead to big churn in F&O stocks

The market regulator’s newly proposed selection criteria for the over Rs 400-trillion-a-day futures and options (F&O) market could pave the way for the entry of popular stocks such as Life......

Pricing challenge in US biz, rich valuations may weigh on pharma stocks

The tailwind of low price erosion in the US generics market, seen by domestic pharmaceutical companies in calendar year 2023 (CY23), may be reversing slowly, caution analysts. Illustration: Uttam......

Weak Q4 may be rare bitter pill for Sun Pharma

Sun Pharmaceutical Industries reported a 34 per cent year-on-year (Y-o-Y) jump in net profit to Rs 2,654.6 crore in Q4FY24. Photograph: Francis Mascarenhas/Reuters The company’s Ebitda......

'I would have been the king of limited overs cricket'

'I am not envious of those who are making millions. It's their era and I had my era.' IMAGE: Cricket legend Salim Durani trains budding cricketers in Jamnagar in this January 2004 photograph.......

Rediff News

Pharmaceuticals Limited

News for Pharmaceuticals Limited

How year's most extravagant wedding was made secure

Over 30% Covaxin takers reported adverse events: Study

AstraZeneca's COVID-19 Vaccine: The TTS Factor

Licences of 14 Patanjali, Divya Pharma products suspended: U'khand to SC

Which Companies Has Amit Shah Invested In?

'Bharat Serums and Vaccines portfolio can touch Rs 5K cr in 3-4 years'

Mankind Pharma to lead in Indian women's health market after BSV deal

Sebi's proposed tweaks likely to lead to big churn in F&O stocks

Pricing challenge in US biz, rich valuations may weigh on pharma stocks

Weak Q4 may be rare bitter pill for Sun Pharma

'I would have been the king of limited overs cricket'

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS